Thus, it is possible to hypothesize that the lower serum SHBG levels and higher bioavailable testosterone levels observed among patients with NAFLD in previous observational studies might be affected by obesity, independent of NAFLD. This evidence concerns the gene SHBG and obesity due to melanocortin 4 receptor deficiency.